|
|
 |
|
Viewing report
|
|
|
|
Aloka Medical Device Company Intelligence Report
Espicom Business Intelligence Ltd, Nov 2010, Pages: 18
The history of Aloka began in 1950 when the medical equipment department of Japan Radio Company became an independent company, Medical and Physical Institute Co Ltd. In 1976, the company’s name was changed to Aloka, which means “ray of hope” in ancient Sanskrit.
Aloka’s operations are divided within three product segments: Electronic Medical Systems (including diagnostic ultrasound systems, bone densitometry systems and medical treatment and surgery systems), General Analysis Systems (including radiation measuring instruments, radio control instruments, analysis systems using radiation and bio-related systems) and Medical Analysis Systems (laboratory test systems, pipettors, and emission and spectroscopic analysis systems). This profile focuses on the Electronic Medical Systems activities.
As a manufacturer of medical ultrasound equipment, Aloka’s most significant achievements include the development of the world’s first diagnostic ultrasound system – the SSD-2 – in 1960 and the first Colour Doppler system in 1983. Aloka's worldwide headquarters is located in Tokyo, Japan. It operates 40 domestic and 16 overseas business establishments, including subsidiaries. The company’s US headquarters is located in Wallingford, Connecticut, and its European headquarters is in Zug, Switzerland. Aloka exports its products to more than 150 countries.
In 1992, Aloka formed a joint venture in Shanghai, China. The joint venture, Shanghai Aloka Medical Equipment Co Ltd, was the first Sino-Japanese joint venture producing medical ultrasonic diagnostic apparatus in China. A joint venture with Trivitron Medical Systems in India was established in April 2009 and is producing ultrasound systems for the Asian markets. Aloka’s competitors include Dräger Medical, GE Healthcare, Siemens, Toshiba and Philips.
In the year ended 31st March 2010, Aloka generated net earnings of ¥662 million on consolidated net sales of ¥45,811 million.
Hitachi Medical is the second-largest shareholder in Aloka, with a 12.34% interest as of 31st March 2010.
This company report provides an overview of the company, including operating activities and latest results, at a glance key events and strategic focus.
The product section of the report focuses on the key aspects of the company's portfolio and technology, covering core products, key brands, new products and analysis of the competition. Sales data, market size and future potential is included where available.
The R&D section answers questions such as:
- Where is the research based?
- How much has been invested in R&D?
- What is in the product pipeline?
- What competing products are in development or already on the market?
- What R&D agreements does the company have?
International Activities include:
The company's revenues, assets and business activities by geographic region and country.
Appendices:
- Agreements
- Mergers & Acquisitions
- Key Corporate Events
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Hitachi Medical Device Company Intelligence Report
Medical Ultrasound Equipment - Global Strategic Business Report
Global Ultrasound Market: Strategic Assessments of Leading Suppliers
Olympus Medical Device Company Intelligence Report
Strategic Assessments of Leading Japanese Diagnostic Imaging Market Players
Global Diagnostic Imaging Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
Shimadzu Medical Device Company Intelligence Report
Strategic Assessments of Leading European Diagnostic Imaging Market Players
Asia-Pacific Diagnostic Imaging Market Outlook to 2016
Global Diagnostic Imaging (CT, MRI, X-Ray & Ultrasound) Market - Competitive Landscape & Forecasts from 2010 to 2016
|
|
|
|
